Corporate Board Profile
Tech Score: 20/100
1 mention(s) identify SHAHRIAR (SHAR) MATIN as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| KORU Medical Systems, Inc. | 2022-03-18 | Mr. Matin has over 20 years of medical device technology experience in Fortune 500 and mid/small cap companies where he led commercial and technical teams in the United States, Europe and Asia. He holds an MBA from Harvard Business School and received a B.E. from the University of California, Berkeley. | Mr. Matin has over 20 years of medical device technology experience including engineering leadership roles and holds a B.E. degree from University of California, Berkeley, indicating technical and software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-05 | Mr. Matin earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School. |
| 2022-03-18 | Mr. Matin has over 20 years of medical device technology experience in Fortune 500 and mid/small cap companies where he led commercial and technical teams in the United States, Europe and Asia. He holds an MBA from Harvard Business School and received a B.E. from the University of California, Berkeley. |
| 2023-03-29 | He earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School. |
| 2024-03-28 | Mr. Matin has over 25 years of medical technology experience and was mostly recently the Chief Executive Officer of Cordis Corporation. He earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors. |
| 2025-04-04 | Mr. Matin has over 25 years of medical technology experience and was mostly recently the Chief Executive Officer of Cordis Corporation, a leading cardiovascular medical device company, from 2021 to 2023. Previously, he was the Chief Operating Officer at ViewRay Technologies Inc., an early-stage radiation oncology medical technology firm, from July 2018 to March 2021. Prior to that, he served as Chief Operating Officer of Spectranetics from January 2014 until its sale to Royal Philips in November 2017. From 2007 – 2014, Mr. Matin held commercial and operation leadership roles of increasing responsibilities at Spectranetics. Mr. Matin started his career in several commercial and engineering leadership roles at Boston Scientific and Guidant Corporation. He earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School. |
Data sourced from SEC filings. Last updated: 2025-07-01